Meeting
2020 Gastrointestinal Cancers Symposium
Clinical and molecular markers of immune checkpoint inhibitor (ICI) response in dMMR colorectal cancer (CRC) patients (pts).
Authors
Ibrahim Halil Sahin
1574, Atlanta, GA
Ibrahim Halil Sahin , Subir Goyal , Yoanna S Pumpalova , Mohamad Bassam Sonbol , Satya Das , Sigurdis Haraldsdottir , Zhengjia Chen , Mehmet Akce , Olatunji B. Alese , Walid Labib Shaib , Daniel H. Ahn , Kristen Keon Ciombor , Jordan Berlin , Tanios S. Bekaii-Saab , Amber Draper , Gregory B. Lesinski , Bassel F. El-Rayes , Christina Wu
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 225)
Abstract #
225
Poster Bd #
L3
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Microsatellite instability (MSI), mismatch repair (MMR), and tumor mutational burden (TMB) as predictive biomarkers for immune checkpoint inhibitor (ICI) effectiveness in real-world patients with metastatic colorectal cancer (mCRC).
First Author: Haley Ellis
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Analysis of concordance between microsatellite instability by next generation sequencing (NGS-MSI) and mismatch repair deficiency by immunohistochemistry (IHC-MMR) in >28,000 colorectal tumors.
First Author: Rouba Ali-Fehmi
Poster
2017 ASCO Annual Meeting
Response to pembrolizumab in patients with mismatch repair deficient (dMMR) colorectal cancer (CRC).
First Author: Alexis Diane Leal
Poster
2012 Gastrointestinal Cancers Symposium
Impact of mismatch repair (MMR) testing on colorectal cancer (CRC) oncology clinical practice.
First Author: Madeleine Hewish